Prognostic Factor | Univariate (n = 403) | Multivariate (n = 360c) | |||
---|---|---|---|---|---|
 | HR (95 % CI) | P-value | HR (95 % CI) | P-value | |
Menacalc | |||||
 | High vs. Low | 1.84 (1.08, 3.14) | 0.0248 | 2.18 (1.19, 4.00) | 0.0199 |
Her2a | |||||
 | Positive vs. Negative | 1.71 (0.77, 3.79) | 0.1855 | 1.43 (0.58, 3.53) | 0.4341 |
Tumor Size | |||||
 | ≥2 cm vs. <2 cm | 1.40 (0.83, 2.35) | 0.2024 | 1.45 (0.80, 2.66) | 0.2234 |
ERa | |||||
 | Negative vs. Positive | 1.18 (0.65, 2.13) | 0.5858 | 1.09 (0.57, 2.08) | 0.7952 |
PRa | |||||
 | Positive vs. Negative | 2.36 (1.32, 4.25) | 0.0040 | NAb | NAb |
Histological grade | |||||
 | Grade 2-3 vs. Grade 1 | 1.62 (0.82, 3.22) | 0.1682 | 1.27 (0.59, 2.72) | 0.5450 |
 | ND vs. Grade 1 | 1.06 (0.33, 3.42) | 0.9264 | 0.75 (0.22, 2.49) | 0.6354 |
Lymphatic invasion | |||||
 | Present vs. Absent | 1.78 (0.97, 3.26) | 0.0614 | 1.67 (0.85, 3.30) | 0.1359 |
Treatment | |||||
 | Yes vs. No | 0.60 (0.35, 1.00) | 0.0514 | 0.54 (0.29, 0.99) | 0.0454 |
Age, years | |||||
 | ≥50 vs. <50 | 1.90 (1.06, 3.43) | 0.0319 | 1.93 (1.02, 3.65) | 0.0425 |